BLU-945 Monotherapy and Combination With Osimertinib in Previously Treated Patients With Advanced EGFR-Mutant (EGFRm) NSCLC in Phase 1/2 SYMPHONY Study
Y. Elamin, M. Nagasaka, E. Shum, L. Bazhenova, J. Rotow, D. Spigel, D. Tan, A. Zalutskaya, F. Albayya, K. Reckamp
{"title":"BLU-945 Monotherapy and Combination With Osimertinib in Previously Treated Patients With Advanced EGFR-Mutant (EGFRm) NSCLC in Phase 1/2 SYMPHONY Study","authors":"Y. Elamin, M. Nagasaka, E. Shum, L. Bazhenova, J. Rotow, D. Spigel, D. Tan, A. Zalutskaya, F. Albayya, K. Reckamp","doi":"10.1016/j.jlb.2023.100125","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":509533,"journal":{"name":"The Journal of Liquid Biopsy","volume":"32 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Liquid Biopsy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jlb.2023.100125","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
